Merck gets FDA Breakthrough Therapy designation for sac-TMT
| RSGRX Fund | USD 33.68 0.13 0.38% |
Slightly above 62% of Victory Rs' investor base is looking to short. The analysis of overall sentiment of trading Victory Rs Growth mutual fund suggests that many investors are alarmed at this time. Victory Rs' investing sentiment can be driven by a variety of factors including economic data, Victory Rs' earnings reports, geopolitical events, and overall market trends.
Victory |
Mercks antibody drug conjugate sac-TMT has received FDA Breakthrough Therapy designation for the treatment of EGFR-mutated lung cancer. Read more here.
Read at seekingalpha.com
 |
Victory Rs Fundamental Analysis
We analyze Victory Rs' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Victory Rs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Victory Rs based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Victory Rs is currently under evaluation in price to sales among similar funds. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Victory Rs Growth Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Victory Rs mutual fund to make a market-neutral strategy. Peer analysis of Victory Rs could also be used in its relative valuation, which is a method of valuing Victory Rs by comparing valuation metrics with similar companies.
Peers
Victory Rs Related Equities
| PDNIX | Pimco Diversified | 0.10 |
| ||
| MDSKX | Blackrock | 0.40 |
| ||
| LIGFX | Lord Abbett | 0.42 |
| ||
| USCAX | Small Cap | 0.53 |
| ||
| PASVX | T Rowe | 0.64 |
| ||
| OIDAX | Oppenheimer International | 0.91 |
|
Other Information on Investing in Victory Mutual Fund
Victory Rs financial ratios help investors to determine whether Victory Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Victory with respect to the benefits of owning Victory Rs security.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stocks Directory Find actively traded stocks across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |